Found: 94
Select item for more details and to access through your institution.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2613, doi. 10.1007/s00262-023-03429-z
- By:
- Publication type:
- Article
A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma.
- Published in:
- Histopathology, 2022, v. 80, n. 6, p. 1004, doi. 10.1111/his.14607
- By:
- Publication type:
- Article
Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4018, doi. 10.3390/cancers15164018
- By:
- Publication type:
- Article
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2846, doi. 10.3390/cancers14122846
- By:
- Publication type:
- Article
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 613, doi. 10.1007/s00228-022-03275-5
- By:
- Publication type:
- Article
Characteristics of compounds with strong or weak nitrification inhibition in sewage.
- Published in:
- Environmental Monitoring & Assessment, 2023, v. 195, n. 12, p. 1, doi. 10.1007/s10661-023-12074-z
- By:
- Publication type:
- Article
Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 7, doi. 10.1634/theoncologist.2020-0379
- By:
- Publication type:
- Article
Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. 306, doi. 10.1634/theoncologist.2019-0728
- By:
- Publication type:
- Article
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 156, doi. 10.1634/theoncologist.2015-0288
- By:
- Publication type:
- Article
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
- Published in:
- BMC Research Notes, 2015, v. 8, p. 1, doi. 10.1186/s13104-015-1762-z
- By:
- Publication type:
- Article
Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 4, p. 1, doi. 10.1007/s00432-024-05649-x
- By:
- Publication type:
- Article
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00485-7
- By:
- Publication type:
- Article
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 282, doi. 10.1016/j.cllc.2021.02.003
- By:
- Publication type:
- Article
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257489
- By:
- Publication type:
- Article
Absence of toxic epidermal necrolysis recurrence with pembrolizumab re‐challenge in a patient with a positive lymphocyte transformation test.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 12, p. e424, doi. 10.1111/1346-8138.15572
- By:
- Publication type:
- Article
Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 3, p. 236, doi. 10.1111/1346-8138.15214
- By:
- Publication type:
- Article
Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1027, doi. 10.21873/invivo.11871
- By:
- Publication type:
- Article
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 29, p. 2909, doi. 10.1111/1759-7714.15077
- By:
- Publication type:
- Article
HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 631, doi. 10.1111/1759-7714.13839
- By:
- Publication type:
- Article
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3585, doi. 10.1111/1759-7714.13721
- By:
- Publication type:
- Article
Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1038, doi. 10.1111/1759-7714.13360
- By:
- Publication type:
- Article
Efficacy of subsequent docetaxel +/− ramucirumab and S‐1 after nivolumab for patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 5, p. 1141, doi. 10.1111/1759-7714.13055
- By:
- Publication type:
- Article
Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 815, doi. 10.1111/1759-7714.13004
- By:
- Publication type:
- Article
Mixed response to osimertinib and the beneficial effects of additional local therapy.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 738, doi. 10.1111/1759-7714.12991
- By:
- Publication type:
- Article
Printed Thermoelectric Devices Using Vanadate Glass Composite Materials.
- Published in:
- Electronics & Communications in Japan, 2015, v. 98, n. 3, p. 41, doi. 10.1002/ecj.11663
- By:
- Publication type:
- Article
Three-axis MEMS combined sensor for electronic stability control system.
- Published in:
- Electronics & Communications in Japan, 2012, v. 95, n. 7, p. 49, doi. 10.1002/ecj.11376
- By:
- Publication type:
- Article
Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2024, v. 65, n. 4, p. 1, doi. 10.1093/ejcts/ezae158
- By:
- Publication type:
- Article
Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 2003, doi. 10.1038/s41416-023-02427-3
- By:
- Publication type:
- Article
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 481, n. 6, p. 893, doi. 10.1007/s00428-022-03437-x
- By:
- Publication type:
- Article
Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 737, doi. 10.1007/s00262-021-03029-9
- By:
- Publication type:
- Article
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 387, doi. 10.1007/s00262-021-02997-2
- By:
- Publication type:
- Article
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1229, doi. 10.1007/s00262-020-02539-2
- By:
- Publication type:
- Article
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 1, p. 15, doi. 10.1007/s00262-019-02431-8
- By:
- Publication type:
- Article
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up results.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 1, p. 56, doi. 10.3892/mco.2016.1076
- By:
- Publication type:
- Article
Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report.
- Published in:
- Medical Oncology, 2010, v. 27, n. 3, p. 753, doi. 10.1007/s12032-009-9280-2
- By:
- Publication type:
- Article
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12451, doi. 10.1038/ncomms12451
- By:
- Publication type:
- Article
Relationships among Smoking Habits, Airflow Limitations, and Metabolic Abnormalities in School Workers.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081145
- By:
- Publication type:
- Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1548, doi. 10.1007/s10637-011-9715-4
- By:
- Publication type:
- Article
Development of the Larval Amphibian Growth and Development Assay: Effects of benzophenone-2 exposure in Xenopus laevis from embryo to juvenile.
- Published in:
- Journal of Applied Toxicology, 2016, v. 36, n. 12, p. 1651, doi. 10.1002/jat.3336
- By:
- Publication type:
- Article
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.
- Published in:
- Science Immunology, 2022, v. 7, n. 76, p. 1, doi. 10.1126/sciimmunol.abk0957
- By:
- Publication type:
- Article